Promoting Health through Vitamin D Therapeutics

Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism


Recent News:

Phase 3 Data Supporting Rayaldee As a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at ENDO 2015 Conference
March 6, 2015

OPKO's Second Rayaldee Phase 3 Trial Meets Primary Endpoints
September 23, 2014

Rayaldee™ Phase 3 Trial Meets Primary Endpoints
August 11, 2014



© 2015 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use